An overview of the microbiome and the effects of antibiotics

Journal for Nurse Practitioners

Volumn 10, Issue 7, 2014, Pages 445-450

  Taggart, Hillary ^a   Bergstrom, Linda ^b  

^a University of Utah ^*

^b UNIVERSITY OF UTAH   (United States)

Author keywords

Clostridium difficile infection; Fecal microbiota transplantation; Inappropriate antibiotic use; Irritable bowel disease; Irritable bowel syndrome; Microbiome; Probiotics

Indexed keywords

EID: 84903592931     PISSN: 15554155     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nurpra.2014.05.005     Document Type: Article

References (44)

1. Turnbaugh P.J., Ley R.E., Hamady M., Fraser-Liggett C.M., Knight R., Gordon J.I. The human microbiome project. Nature 2007, 449(7164):804-810.
2. Dominguez-Bello M.G., Costello E.K., Contreras M., et al. Delivery mode shapes the acquisition and structure of the initial microbiota across multiple body habitats in newborns. Proc Natl Acad Sci U S A 2010, 107(26):11971-11975.
3. Koenig J.E., Spor A., Scalfone N., et al. Succession of microbial consortia in the developing infant gut microbiome. Proc Natl Acad Sci U S A 2011, 108(Suppl 1):4578-4585.
4. Palmer C., Bik E.M., DiGiulio D.B., Relman D.A., Brown P.O. Development of the human infant intestinal microbiota. PLoS Biol 2007, 5(7):e177.
5. Ursell L.K., Metcalf J.L., Parfrey L.W., Knight R. Defining the human microbiome. Nutr Rev 2012, 70(suppl 1):S38-S44.
6. Arora T., Sharma R. Fermentation potential of the gut microbiome: implications for energy homeostasis. Nutr Rev 2011, 69(2):99-106.
7. Simren M., Barbara G., Flint H.J., et al. Intestinal microbiota in functional bowel disorders: a Rome foundation report. Gut 2013, 62(1):159-176.
8. Sokol H., Pigneur B., Watterlot L., et al. Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients. Proc Natl Acad Sci U S A 2008, 105(43):16731-16736.
9. Kelly D., Mulder I.E. Microbiome and immunological interactions. Nutr Rev 2012, 70(suppl 1):S18-S30.
10. Douglas-Escobar M., Elliott E., Neu J. Effect of intestinal microbial ecology on the developing brain. JAMA Pediatr 2013, 167(4):374-379.
11. Ueda Y., Kayama H., Jeon S.G., et al. Commensal microbiota induce LPS hyporesponsiveness in colonic macrophages via the production of IL-10. Int Immunol 2010, 22(12):953-962.
12. Proal A.D., Albert P.J., Marshall T.G. The human microbiome and autoimmunity. Curr Opin Rheumatol 2013, 25(2):234-240.
13. Cannistraro P.A., Rauch S.L. Neural circuitry of anxiety: evidence from structural and functional neuroimaging studies. Psychopharmacol Bull 2003, 37(4):8-25.
14. Sah P., Faber E.S., Lopez De Armentia M., Power J. The amygdaloid complex: anatomy and physiology. Physiol Rev 2003, 83(3):803-834.
15. Forsythe P., Kunze W.A., Bienenstock J. On communication between gut microbes and the brain. Curr Opin Gastroenterol 2012, 28(6):557-562.
16. Bested A.C., Logan A.C., Selhub E.M. Intestinal microbiota, probiotics and mental health: from Metchnikoff to modern advances: part III-convergence toward clinical trials. Gut Pathog 2013, 5(1):4.
17. Bercik P., Verdu E.F., Foster J.A., et al. Chronic gastrointestinal inflammation induces anxiety-like behavior and alters central nervous system biochemistry in mice. Gastroenterology 2010, 139(6):2102-2112.e2101.
18. Cryan J.F., O'Mahony S.M. The microbiome-gut-brain axis: from bowel to behavior. Neurogastroenterol Motil 2011, 23(3):187-192.
19. Johnson C.L., Versalovic J. The human microbiome and its potential importance to pediatrics. Pediatrics 2012, 129(5):950-960.
20. Dethlefsen L., Huse S., Sogin M.L., Relman D.A. The pervasive effects of an antibiotic on the human gut microbiota, as revealed by deep 16S rRNA sequencing. PLoS Biol 2008, 6(11):e280.
21. Dethlefsen L., Relman D.A. Incomplete recovery and individualized responses of the human distal gut microbiota to repeated antibiotic perturbation. Proc Natl Acad Sci U S A 2011, 108(suppl 1):4554-4561.
22. Jakobsson H.E., Jernberg C., Andersson A.F., Sjolund-Karlsson M., Jansson J.K., Engstrand L. Short-term antibiotic treatment has differing long-term impacts on the human throat and gut microbiome. PLoS One 2010, 5(3):e9836.
23. Costelloe C., Metcalfe C., Lovering A., Mant D., Hay A.D. Effect of antibiotic prescribing in primary care on antimicrobial resistance in individual patients: systematic review and meta-analysis. BMJ 2010, 340:c2096.
24. Stewardson A.J., Huttner B., Harbarth S. At least it won't hurt: the personal risks of antibiotic exposure. Curr Opin Pharmacol 2011, 11(5):446-452.
25. Sharland M. The use of antibacterials in children: a report of the Specialist Advisory Committee on Antimicrobial Resistance (SACAR) Paediatric Subgroup. JAntimicrob Chemother 2007, 60(suppl 1):i15-i26.
26. Hviid A., Svanstrom H., Frisch M. Antibiotic use and inflammatory bowel diseases in childhood. Gut 2011, 60(1):49-54.
27. Ajslev T.A., Andersen C.S., Gamborg M., Sorensen T.I., Jess T. Childhood overweight after establishment of the gut microbiota: the role of delivery mode, pre-pregnancy weight and early administration of antibiotics. Int J Obes (Lond) 2011, 35(4):522-529.
28. Rotjanapan P., Dosa D., Thomas K.S. Potentially inappropriate treatment of urinary tract infections in two Rhode Island nursing homes. Arch Intern Med 2011, 171(5):438-443.
29. O'Brien J.A., Lahue B.J., Caro J.J., Davidson D.M. The emerging infectious challenge of clostridium difficile-associated disease in Massachusetts hospitals: clinical and economic consequences. Infect Control Hosp Epidemiol 2007, 28(11):1219-1227.
30. Thorpe J.M., Smith S.R., Trygstad T.K. Trends in emergency department antibiotic prescribing for acute respiratory tract infections. Ann Pharmacother 2004, 38(6):928-935.
31. Grijalva C.G., Nuorti J.P., Griffin M.R. Antibiotic prescription rates for acute respiratory tract infections in US ambulatory settings. JAMA 2009, 302(7):758-766.
32. Barnett M.L., Linder J.A. Antibiotic prescribing to adults with sore throat in the United States, 1997-2010. JAMA Intern Med 2014, 174(1):138-140.
33. Hersh A.L., Shapiro D.J., Pavia A.T., Shah S.S. Antibiotic prescribing in ambulatory pediatrics in the United States. Pediatrics 2011, 128(6):1053-1061.
34. De Filippo C., Cavalieri D., Di Paola M., et al. Impact of diet in shaping gut microbiota revealed by a comparative study in children from Europe and rural Africa. Proc Natl Acad Sci U S A 2010, 107(33):14691-14696.
35. Turnbaugh P.J., Ridaura V.K., Faith J.J., Rey F.E., Knight R., Gordon J.I. The effect of diet on the human gut microbiome: a metagenomic analysis in humanized gnotobiotic mice. Sci Transl Med 2009, 1(6):6ra14.
36. Wu G.D., Chen J., Hoffmann C., et al. Linking long-term dietary patterns with gut microbial enterotypes. Science 2011, 334(6052):105-108.
37. Johnston B.C., Goldenberg J.Z., Vandvik P.O., Sun X., Guyatt G.H. Probiotics for the prevention of pediatric antibiotic-associated diarrhea. Cochrane Database Syst Rev 2011, 11:Cd004827.
38. Thomas D.W., Greer F.R. Probiotics and prebiotics in pediatrics. Pediatrics 2010, 126(6):1217-1231.
39. Kim J.Y., Kwon J.H., Ahn S.H., et al. Effect of probiotic mix (Bifidobacterium bifidum, Bifidobacterium lactis, Lactobacillus acidophilus) in the primary prevention of eczema: a double-blind, randomized, placebo-controlled trial. Pediatr Allergy Immunol 2010, 21(2 Pt 2):e386-e393.
40. Luoto R., Laitinen K., Nermes M., Isolauri E. Impact of maternal probiotic-supplemented dietary counselling on pregnancy outcome and prenatal and postnatal growth: a double-blind, placebo-controlled study. Br J Nutr 2010, 103(12):1792-1799.
41. Burke K.E., Lamont J.T. Fecal Transplantation for Recurrent Clostridium difficile Infection in Older. JAm Geriatr Soc 2013, 61(8):1394-1398.
42. Aroniadis O.C., Brandt L.J. Fecal microbiota transplantation: past, present and future. Curr Opin Gastroenterol 2013, 29(1):79-84.
43. Aleccia J. Poop pills are latest way to cure dangerous C. diff infections, new study shows. NBC News October 3, 2013, Accessed May 30, 2014. http://www.nbcnews.com/health/health-news/poop-pills-are-latest-way-cure-dangerous-c-diff-infections-f8C11300066.
44. Gough E., Shaikh H., Manges A.R. Systematic review of intestinal microbiota transplantation (fecal bacteriotherapy) for recurrent Clostridium difficile infection. Clin Infect Dis 2011, 53(10):994-1002.